rfhg_159505.1

Basic information about the TSS

---

TSS ID: rfhg_159505.1 Species: human Chr: chr13		Start: 32523388 End: 32523391 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK123084:432 GeneID: 10443 HGNC/MGI_ID: HGNC:26916 UniProt_ID: Nearer transcript ids and distances:

Gene_name: NEDD4 binding protein 2 like 2 Gene_symbol: N4BP2L2 Gene_synonyms: CG005 PFAAP5 Gene_source: HGNC:26916

TATA-Box annotation

---

Distance to TSS:	-13994
Nearest PromoterID:	NR_026928
Entrez ID:	116828
Nearest Unigene:	Hs.658751
Nearest Refseq:	NR_026928
Nearest Ensembl:	ENSG00000281026
Gene Name:	NEDD4 binding protein 2 like 2
Gene Alias:	CG030
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	0.500000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@N4BP2L2 p2@N4BP2L2 p3@N4BP2L2 p4@N4BP2L2 p5@N4BP2L2
Sample		p1@N4BP2L2	p2@N4BP2L2	p3@N4BP2L2	p4@N4BP2L2	p5@N4BP2L2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	37.21	10.13	0.39	1.36	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	30.15	7.89	0.00	2.43	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	35.88	8.87	0.39	2.70	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	31.81	6.86	0.42	1.87	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	23.85	6.30	0.67	1.57	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	26.16	6.78	0.78	2.13	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	45.10	15.03	0.65	2.40	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	39.72	9.69	0.73	2.66	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	31.84	6.84	1.07	0.85	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	35.36	25.50	1.16	5.80	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	37.19	32.34	0.40	3.64	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	39.84	21.55	0.81	7.32	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	36.75	2.42	0.81	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	38.94	3.01	0.45	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	43.25	3.51	0.88	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	32.44	2.77	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	33.20	1.75	1.09	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	27.00	1.27	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	28.79	2.13	0.53	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	35.35	3.01	0.60	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	25.13	1.74	0.40	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	37.46	3.11	1.04	0.86	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	32.96	2.84	1.03	0.13	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	28.15	3.15	1.46	1.21	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	36.38	1.81	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	27.22	2.22	0.32	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	29.67	4.40	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	46.91	3.77	1.65	1.18	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.49	2.42	0.97	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	36.01	3.80	1.45	0.18	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	28.89	2.09	0.63	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	27.55	1.95	0.98	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	31.23	1.48	0.63	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	47.01	5.11	0.82	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	39.08	2.43	0.56	1.12	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	28.55	3.07	0.19	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	32.09	2.45	1.02	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	33.85	2.82	0.81	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	32.41	3.51	1.35	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	34.33	2.64	1.68	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	31.05	3.06	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	41.43	4.10	1.90	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	44.50	5.48	1.48	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	40.56	4.90	0.52	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	44.97	3.81	0.60	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	46.06	6.05	0.47	1.16	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	39.34	4.32	0.72	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	37.26	5.07	1.19	1.49	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	37.58	6.22	0.48	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	44.69	3.84	1.42	1.01	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	53.70	4.30	0.41	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	50.03	3.34	1.11	1.33	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	867.52	69.96	55.97	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	33.36	2.13	1.06	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	42.42	5.30	1.33	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	207.22	20.97	2.52	3.36	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	81.75	11.02	1.38	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	46.02	5.51	1.62	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	28.91	1.61	0.64	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	85.81	8.17	2.83	1.89	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.84	2.82	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	39.26	2.80	1.12	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	126.59	14.33	2.39	4.78	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	75.77	7.47	1.36	1.36	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	47.76	4.55	1.62	0.65	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	39.40	3.90	0.71	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	889.02	64.66	48.49	32.33	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	726.57	23.69	31.59	7.90	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	29.25	3.41	0.00	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	26.28	5.45	0.50	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.99	2.81	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	42.39	6.62	0.99	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	30.93	3.71	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	27.21	2.45	0.92	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	26.45	2.06	1.74	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	19.25	1.44	0.00	1.12	0.16
Adipocyte - omental, donor1	11473-119C6	30.28	3.44	1.65	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	25.41	0.75	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	22.10	1.00	1.00	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	19.14	2.55	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.94	0.90	0.45	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	7.47	0.52	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	45.96	4.50	1.56	0.59	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	29.08	0.51	2.06	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	29.27	1.12	1.67	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	36.44	0.59	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	48.58	3.06	2.01	0.24	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	36.79	4.52	2.90	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	23.46	2.13	2.13	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	26.71	1.67	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	21.63	1.66	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	30.64	2.01	0.75	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	25.20	0.98	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	25.58	1.22	0.30	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	9.06	0.44	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	0.72	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	12.41	0.54	0.18	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	7.60	0.41	0.41	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	23.91	2.06	1.03	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	11.02	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	26.51	1.35	1.35	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.33	1.74	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	2.14	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	21.82	1.20	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	2.53	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	0.00	1.32	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.00	1.62	0.32	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.02	1.46	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.59	1.13	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	12.34	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	19.44	1.81	1.32	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.59	0.90	0.30	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.07	1.07	1.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.44	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.89	1.34	0.00	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	8.78	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.61	1.00	0.50	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.21	1.54	0.34	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.93	1.46	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.97	1.14	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	4.85	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	18.24	1.14	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	15.82	1.92	0.43	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.00	0.52	0.77	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.73	1.41	0.47	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.97	0.64	1.29	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.99	2.14	1.43	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.87	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.95	1.20	0.90	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	9.50	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	18.82	2.54	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.88	1.53	1.02	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.90	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.93	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.93	1.06	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.67	1.16	0.00	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	11.34	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.94	1.19	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.08	0.21	0.21	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.83	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.04	5.10	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.94	1.61	0.69	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	10.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.44	1.78	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.56	1.65	0.62	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	9.18	1.84	0.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.99	0.96	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	11.97	1.77	1.11	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	16.06	2.22	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	12.71	1.59	0.79	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.45	0.73	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	18.79	3.19	0.00	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	6.16	0.86	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	6.50	1.26	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	62.40	7.67	1.39	1.05	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	27.83	3.88	0.81	0.00	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	28.94	2.83	0.89	0.30	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	55.28	8.03	2.52	1.03	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	54.00	6.89	2.88	0.75	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	52.57	8.08	2.50	1.02	0.57
Basophils, donor1	12241-129G9	38.97	6.54	1.83	0.26	0.26
Basophils, donor2	12242-129H1	75.41	8.30	11.18	1.80	0.36
Basophils, donor3	12243-129H2	30.43	1.62	3.09	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	5.39	0.43	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.30	0.00	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	1.87	0.21	0.42	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	8.29	0.92	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	19.79	0.90	0.54	0.00	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	30.09	3.50	1.34	0.31	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	54.03	5.12	2.10	1.40	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	77.39	8.95	2.56	0.96	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	31.03	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	49.59	3.38	5.07	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	35.45	3.16	3.34	0.74	0.56
CD14+ Monocytes, donor3	11381-118B4	34.25	4.61	2.63	0.44	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	123.69	4.81	6.51	0.57	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	135.33	6.82	4.55	0.38	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	173.25	8.88	4.27	0.66	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	80.08	2.89	3.18	0.43	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	70.61	6.94	0.60	1.21	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	92.15	4.74	2.13	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	56.75	4.18	1.84	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	52.17	5.52	1.93	0.83	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	99.67	7.69	2.98	2.48	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	60.89	4.70	2.35	1.17	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	67.66	5.52	2.49	1.42	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	131.67	12.84	5.66	1.52	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	62.51	5.62	3.51	0.47	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	94.52	6.34	4.75	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	64.34	5.55	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	54.14	4.61	2.68	0.45	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	82.81	7.98	2.20	1.60	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	135.33	11.66	5.62	1.04	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	77.79	7.55	2.97	0.46	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	125.77	11.31	2.49	1.58	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	103.00	6.11	3.93	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	69.94	8.88	4.03	0.54	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	85.66	8.55	2.97	1.05	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	108.57	10.52	3.37	1.26	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	65.77	5.51	2.57	1.47	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	89.48	9.16	3.17	1.06	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	116.26	5.70	3.07	3.07	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	60.33	4.88	3.31	1.39	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	66.16	6.32	1.49	1.86	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	138.17	12.29	4.96	1.94	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	56.92	4.91	3.28	0.41	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	117.52	12.98	3.01	1.16	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	155.20	10.44	3.71	1.39	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	75.63	4.58	4.14	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	74.15	4.62	4.85	0.69	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	72.35	3.25	4.12	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	98.88	4.83	6.23	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	90.47	2.79	5.41	0.87	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	197.33	6.02	10.03	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	59.20	3.32	6.12	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	87.83	4.61	7.90	1.10	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	92.22	4.63	4.42	0.84	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	83.32	10.16	8.13	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	146.44	14.24	8.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	106.67	8.28	7.25	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	148.72	11.73	12.26	2.67	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	157.07	17.69	10.72	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	122.84	13.34	7.72	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	104.32	7.84	5.49	1.57	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	133.15	10.55	10.55	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	104.38	10.68	3.29	1.64	0.82
CD19+ B Cells, donor2	11624-122B4	103.74	13.06	2.18	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	88.85	12.12	6.56	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	179.40	3.23	6.46	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	116.65	2.80	3.99	0.40	2.00
CD34+ Progenitors, donor1	11545-120B6	53.21	9.04	2.01	3.01	1.00
CD34+ Progenitors, donor2	11625-122B5	96.07	29.78	8.43	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	88.30	8.27	2.25	2.25	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	90.64	7.89	3.83	0.68	0.23
CD4+ T Cells, donor1	11225-116C1	187.81	20.71	18.92	2.86	1.07
CD4+ T Cells, donor2	11306-117C1	65.52	6.74	11.63	3.67	2.45
CD4+ T Cells, donor3	11382-118B5	75.94	10.67	5.18	1.52	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	170.24	11.23	11.74	1.02	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	125.55	8.98	11.45	0.45	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	121.88	9.49	11.21	0.86	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	182.05	17.54	20.39	4.27	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	208.59	24.58	25.28	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	145.03	36.26	9.89	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	111.85	10.98	6.07	1.73	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	72.70	4.91	4.91	1.53	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	73.35	4.35	7.90	0.81	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	131.80	16.14	14.79	2.69	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	169.10	10.48	14.32	1.75	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	253.43	22.00	14.08	2.20	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	137.03	8.43	8.01	1.69	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	64.62	4.78	3.32	0.62	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	67.83	4.34	2.67	1.67	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	209.66	16.59	23.66	2.18	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	317.82	22.51	27.87	2.68	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	199.05	14.35	10.76	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	155.02	9.64	10.20	0.56	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	95.74	7.36	7.15	0.43	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	112.64	7.36	6.94	0.63	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	120.84	17.70	9.61	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	155.10	13.00	12.13	2.60	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	304.20	27.89	21.79	4.36	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	200.42	10.89	15.84	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	169.87	12.00	12.92	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	171.69	8.37	20.94	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	324.28	20.22	20.22	0.83	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	356.80	20.61	17.42	2.21	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	203.28	9.24	12.32	3.08	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	212.72	11.82	18.98	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	188.36	5.54	11.08	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	111.97	17.35	12.77	2.95	0.00
CD8+ T Cells, donor2	11307-117C2	51.06	8.63	6.76	3.75	1.13
CD8+ T Cells, donor3	11383-118B6	89.38	12.12	11.61	2.02	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	17.66	2.52	1.38	0.92	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.82	3.12	0.24	0.48	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	15.32	3.56	0.27	1.37	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	30.32	2.40	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	14.88	3.12	0.72	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	18.19	1.59	0.68	0.91	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	18.90	1.96	0.65	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	18.16	1.32	1.05	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.48	1.88	0.94	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	19.92	2.11	0.30	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	18.88	1.45	0.29	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	17.58	3.20	0.00	1.07	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.76	2.19	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	19.13	1.82	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	31.33	0.00	2.24	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.89	1.44	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	20.72	3.45	0.58	0.58	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.73	1.65	0.24	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	26.94	2.85	0.32	1.27	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	19.07	2.46	0.31	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	17.31	1.60	1.28	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	22.18	2.29	0.38	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	19.31	2.76	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	15.88	3.03	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	59.42	4.01	0.80	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	51.06	9.79	1.40	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	79.14	9.02	5.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	45.69	9.14	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	15.32	0.99	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	18.63	2.32	0.74	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	28.08	2.08	1.73	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	15.28	1.78	0.71	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	13.88	1.25	0.80	0.11	0.34
Chondrocyte - re diff, donor2	11339-117F7	56.40	6.27	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	25.07	2.43	0.81	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	53.25	8.95	1.61	0.80	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	20.95	3.85	1.71	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	19.74	4.25	0.71	0.62	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	54.38	4.40	3.94	0.37	0.09
Corneal Epithelial Cells, donor1	11526-119I5	2.42	0.44	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	6.83	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	7.16	0.26	0.51	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	49.53	3.14	3.63	0.33	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	46.68	2.52	2.21	0.63	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	6.90	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	24.30	1.84	1.62	0.00	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	68.67	14.35	3.42	1.02	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	56.80	16.97	3.26	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	65.33	16.94	4.84	3.87	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	13.84	0.83	0.67	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	8.21	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	11.59	0.28	0.85	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	6.29	0.79	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	7.56	0.00	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	9.18	0.47	0.00	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	6.66	0.53	0.88	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	41.01	1.77	1.11	0.44	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	47.77	2.74	1.22	0.61	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	66.53	5.36	1.97	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	12.48	1.19	0.59	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	7.29	0.52	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	5.25	0.14	0.43	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	32.81	1.60	0.80	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	6.81	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	62.74	7.21	2.24	0.25	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	33.68	1.30	0.43	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	25.65	2.08	1.22	0.12	0.37
Endothelial Cells - Vein, donor1	11267-116G7	10.24	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.08	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	12.56	0.31	0.31	0.00	0.00
Eosinophils, donor1	12244-129H3	45.74	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	156.77	9.90	13.20	1.65	0.00
Eosinophils, donor3	12246-129H5	92.74	10.70	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.91	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	31.20	2.87	0.00	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.80	0.66	0.33	0.22	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	11.38	0.98	0.76	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	21.71	2.91	1.09	0.24	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	98.67	12.56	5.46	1.36	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.29	1.37	0.53	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	113.04	9.75	1.58	1.84	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	22.26	2.33	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	18.15	1.36	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	9.85	0.76	0.00	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	6.31	1.10	0.63	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	59.71	3.33	1.82	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	33.38	2.66	0.63	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	31.23	1.97	0.91	0.45	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	24.25	2.81	0.13	0.67	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	17.26	1.29	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	2.93	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	11.99	2.08	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	41.55	2.04	1.53	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	10.57	0.94	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	11.79	0.47	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	9.67	0.60	0.12	0.24	0.00
Fibroblast - Dermal, donor4	11450-119A1	34.93	1.92	0.68	0.34	0.23
Fibroblast - Dermal, donor5	11454-119A5	30.01	0.87	1.05	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	40.93	0.97	1.62	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	43.31	1.87	2.08	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	48.21	3.93	0.79	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	22.40	1.05	1.45	0.26	0.66
Fibroblast - Gingival, donor3	11394-118C8	36.74	2.42	0.77	0.29	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	39.48	3.12	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	16.03	1.94	0.18	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	29.46	2.96	1.09	0.94	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	26.64	1.76	1.08	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	4.23	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	27.35	0.88	1.46	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	33.41	1.50	1.09	0.41	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	35.76	2.30	1.76	0.33	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	53.56	4.55	0.88	0.44	0.15
Fibroblast - Lung, donor1	11270-116H1	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	43.27	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	8.65	0.42	0.21	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	7.50	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.84	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	10.15	0.00	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	41.32	1.55	2.13	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	32.46	1.52	1.06	0.30	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	56.30	2.75	1.22	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	35.49	1.14	0.76	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	15.93	1.89	1.35	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.11	1.04	0.70	0.12	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	23.32	1.77	1.22	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	10.97	0.41	0.81	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	4.01	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	9.09	1.19	0.79	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	99.82	8.33	3.97	0.99	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	39.96	3.91	1.42	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	40.80	3.35	1.97	0.59	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	71.90	4.51	2.41	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	74.27	4.75	2.16	0.43	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	112.11	7.09	2.78	1.01	0.76
Fibroblast - skin normal, donor1	11553-120C5	37.74	2.46	1.31	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	115.29	8.22	5.61	0.80	1.00
Fibroblast - skin normal, donor2	11561-120D4	53.85	5.53	1.11	0.50	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	111.83	11.18	1.81	0.60	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	49.38	5.30	2.40	0.17	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	82.06	4.62	1.88	0.34	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	97.54	6.90	1.64	1.64	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	46.34	3.20	1.07	0.64	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	19.74	1.52	0.67	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.47	2.51	0.94	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	398.88	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	91.51	3.49	3.49	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	20.28	1.21	0.69	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.52	1.82	1.82	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	31.17	3.07	2.30	0.51	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	11.48	4.59	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	21.06	3.83	0.64	2.55	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	82.73	14.26	1.43	3.99	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	48.26	8.82	0.55	2.76	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	37.22	12.56	1.14	1.60	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	46.96	8.12	0.40	2.77	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	44.94	14.80	0.26	1.32	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	40.77	9.78	0.98	0.98	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	54.39	14.15	0.00	1.33	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	27.56	9.04	0.71	0.99	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	26.48	9.11	0.12	1.23	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	11.28	5.91	0.27	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	22.80	6.32	0.50	0.50	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	26.99	6.51	0.55	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	25.82	10.17	0.00	1.42	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	17.11	5.25	0.23	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	24.04	5.98	0.75	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	24.26	3.28	0.66	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	22.75	4.43	0.59	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	30.36	6.04	0.95	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	22.57	5.81	1.12	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	24.80	4.44	0.60	1.01	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	37.83	7.80	1.02	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	38.93	10.82	1.60	0.98	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	51.40	9.16	2.19	0.42	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	62.67	6.66	1.71	0.85	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	39.95	7.64	1.11	0.22	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.93	8.40	0.50	1.00	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	42.06	5.51	1.02	1.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	31.36	4.33	0.62	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	36.09	4.96	0.81	1.04	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	30.68	5.67	1.50	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.70	4.19	0.88	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	42.68	5.90	0.49	0.74	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	34.53	5.67	0.97	0.97	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	33.03	6.41	0.96	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	24.83	3.41	1.04	0.57	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	21.83	3.01	0.63	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	40.44	2.13	1.82	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	31.78	3.55	0.94	0.94	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	28.32	2.63	0.88	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	33.67	4.21	0.56	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	27.04	1.67	0.74	0.37	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	27.54	3.21	1.07	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	22.80	2.45	1.07	0.31	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	22.54	2.20	0.39	0.39	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	24.40	2.98	1.36	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	26.73	2.77	1.11	0.37	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	31.58	2.63	0.66	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	43.64	4.96	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	24.14	2.64	0.40	0.53	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	20.58	1.41	0.20	0.81	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	50.32	6.35	1.27	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	54.34	19.31	0.80	1.59	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	26.66	10.32	0.77	0.46	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	43.17	12.07	1.02	2.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	16.27	4.69	0.31	1.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	14.69	8.19	0.28	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.53	7.38	0.46	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	12.37	0.00	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	26.69	7.35	0.39	1.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	17.65	25.67	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	23.11	7.81	0.33	1.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	38.30	13.18	0.00	4.12	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	0.00	0.00	10.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.08	10.07	0.56	2.24	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	26.15	8.50	1.31	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	42.78	18.45	1.68	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	33.40	14.00	0.32	1.91	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	32.61	9.85	1.36	2.04	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	43.85	16.71	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	28.06	9.16	2.29	1.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.69	5.62	0.89	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	47.44	10.16	1.69	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	31.89	11.18	0.41	2.90	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	27.85	9.90	0.23	2.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	21.07	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.91	9.99	0.00	1.92	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	31.29	10.76	1.63	1.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	45.48	6.02	0.67	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	47.77	11.56	1.93	3.85	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	32.52	14.04	0.68	3.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	74.54	17.39	4.97	4.97	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	57.09	7.55	1.42	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	38.02	4.22	0.00	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	50.87	12.21	0.00	3.56	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	55.84	13.96	1.99	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	70.55	14.31	0.99	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	86.17	21.25	2.36	3.54	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	37.92	11.09	1.75	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	44.77	8.78	0.88	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	33.06	16.95	1.70	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	29.25	8.36	1.19	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	36.39	11.16	0.00	1.94	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	12.55	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.64	0.83	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	2.25	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	17.13	2.54	0.32	0.63	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.86	0.42	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	14.39	1.16	0.81	0.12	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.70	1.18	0.84	0.51	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	14.56	0.68	0.46	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	15.85	1.31	0.77	0.44	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	13.97	1.50	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	14.85	1.29	0.22	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	10.09	1.00	0.87	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	11.67	0.86	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.81	1.28	0.96	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.95	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.46	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	9.88	0.71	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	12.06	1.57	0.00	0.35	0.00
Hepatocyte, donor1	11523-119I2	65.37	8.47	0.00	1.21	2.42
Hepatocyte, donor2	11603-120I1	70.03	5.39	5.39	0.00	2.15
Hepatocyte, donor3	11684-122I1	94.48	6.75	7.98	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	79.63	22.19	3.26	3.26	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	51.39	10.49	1.75	0.70	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	18.93	2.47	0.55	0.55	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	1.32	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.93	0.00	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	3.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	3.26	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	3.69	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2.36	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	5.44	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	1.43	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	3.70	0.00	0.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	7.65	2.78	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	4.36	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	10.85	1.31	0.73	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	5.27	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	18.27	1.23	0.85	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	26.34	1.93	1.02	0.45	0.00
Keratocytes, donor1	11527-119I6	12.03	1.38	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	3.52	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	17.59	1.58	1.38	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	52.75	4.40	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	20.50	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	41.87	3.00	1.38	0.00	0.35
Lens Epithelial Cells, donor3	11690-122I7	29.36	3.43	1.01	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	17.19	1.07	0.71	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	4.19	1.12	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	26.29	3.46	0.79	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	14.52	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	2.52	0.95	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.73	0.54	0.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	20.11	0.00	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.77	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.99	1.13	0.70	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.87	2.77	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.21	1.36	0.58	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.52	0.19	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	17.07	0.70	0.70	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.11	1.19	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.77	0.27	0.27	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.94	1.54	0.62	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.74	0.62	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	4.94	2.38	0.18	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.90	0.99	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.93	0.29	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.73	0.50	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	12.12	1.45	0.97	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	10.50	0.81	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	13.02	1.67	0.45	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.89	1.56	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.12	2.72	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.82	0.15	0.30	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	12.38	1.38	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.28	0.75	0.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.71	0.21	0.11	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.66	1.94	0.48	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.62	0.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.45	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.99	2.59	0.37	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.65	2.22	0.99	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.44	1.10	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.40	1.93	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	16.43	2.43	0.30	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.14	2.38	0.28	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	13.87	1.78	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	0.48	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.20	0.93	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	9.31	1.43	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.84	0.65	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	15.47	1.61	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.33	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.86	0.30	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	15.34	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	16.33	1.48	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	13.12	0.85	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.14	2.81	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	9.34	0.93	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	18.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	17.84	2.38	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	19.45	1.13	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	26.47	3.20	0.87	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.96	1.80	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	20.19	1.63	0.41	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.51	3.08	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.17	2.47	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	22.65	2.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	21.90	2.04	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	25.08	1.60	2.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	30.61	1.32	1.32	0.57	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.79	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	21.20	2.45	1.63	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	26.03	2.71	1.46	0.62	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	32.79	3.36	0.28	1.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	17.52	2.06	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	25.84	1.45	1.16	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	18.23	1.20	1.20	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	21.58	1.66	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	20.15	1.06	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.64	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	6.91	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	20.34	1.15	0.38	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	12.45	1.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.13	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.10	0.90	1.36	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.95	2.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.91	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	14.49	0.74	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	16.37	0.43	1.72	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	15.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.33	0.67	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.08	0.60	0.00	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	1.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	15.81	1.37	0.69	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.01	1.07	1.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.87	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	22.97	1.11	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	13.61	0.40	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	9.45	2.18	0.00	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.80	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	18.25	0.49	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	22.58	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.08	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	14.87	0.90	0.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	5.16	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	25.38	0.89	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	17.21	0.39	0.78	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.13	4.62	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	17.12	1.56	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	24.07	2.19	1.31	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	26.84	1.68	0.56	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	22.08	0.44	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.91	2.31	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	19.24	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	24.51	1.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.66	1.19	0.40	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	20.66	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.22	2.08	0.00	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	21.66	1.90	2.28	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	20.66	1.55	1.03	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	18.74	1.81	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	21.87	2.22	0.32	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	14.39	2.67	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	15.52	2.87	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	23.14	2.57	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.85	1.41	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.05	1.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	14.56	0.83	0.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	23.49	1.57	1.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	17.95	2.51	0.84	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	11.62	1.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.71	1.34	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	13.37	0.53	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.82	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	13.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	14.23	0.89	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	15.96	1.14	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.80	1.53	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	15.87	2.74	0.00	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	13.81	0.45	1.34	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	17.68	2.08	0.26	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.94	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	0.00	0.00	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	61.54	2.73	1.82	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	38.90	2.39	2.75	0.73	0.18
Macrophage - monocyte derived, donor3	11389-118C3	27.00	1.97	1.97	0.26	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.43	1.06	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	40.41	3.49	2.38	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	31.13	4.17	1.53	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	42.55	3.29	1.40	0.20	0.00
Mammary Epithelial Cell, donor2	11350-117G9	35.61	2.32	1.16	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	2.99	0.25	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	381.68	35.25	10.85	11.52	0.68
Mast cell, donor1	11563-120D6	96.79	4.87	5.84	0.65	0.76
Mast cell, donor2	11565-120D8	121.54	6.24	15.75	0.30	0.59
Mast cell, donor3	11566-120D9	158.49	3.38	15.08	0.68	0.90
Mast cell, donor4	11567-120E1	124.63	3.72	9.04	0.71	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	149.82	3.66	8.65	0.33	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	98.06	5.84	7.00	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	94.07	3.44	4.36	0.23	0.23
Mast cell, expanded, donor8	11941-126A6	102.09	5.52	5.86	0.67	0.50
Melanocyte - dark, donor1	11502-119F8	32.04	2.49	1.09	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	12.81	0.69	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	34.77	1.09	1.88	0.22	0.07
Melanocyte - light, donor1	11274-116H5	11.75	0.71	0.94	0.00	0.00
Melanocyte - light, donor2	11351-117H1	4.78	0.00	0.68	0.68	0.00
Melanocyte - light, donor3	11423-118G1	2.60	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	27.18	1.35	1.25	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	18.02	2.15	1.08	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	34.02	1.87	0.80	0.54	0.54
Meningeal Cells, donor1	11493-119E8	23.94	1.49	0.50	0.00	0.12
Meningeal Cells, donor2	11573-120E7	17.61	2.20	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	32.03	2.20	1.47	0.24	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	22.53	3.14	0.57	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	34.62	4.23	1.61	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	8.61	2.15	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	37.48	2.33	1.06	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.11	2.51	1.51	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.25	0.44	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.96	1.46	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	4.71	0.00	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	28.81	2.77	0.42	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.66	0.37	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	32.24	5.26	0.92	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.20	0.30	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	4.48	0.64	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	24.46	0.35	0.71	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	25.33	2.50	0.94	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	7.98	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	26.52	1.59	1.86	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	12.01	2.50	1.00	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	18.86	2.46	1.16	0.36	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	25.66	1.35	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	44.82	3.20	1.72	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	19.43	2.06	1.77	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	44.63	2.17	3.41	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	15.35	2.28	1.04	0.62	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	36.29	0.75	1.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	14.90	2.33	2.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	29.47	2.44	1.42	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.03	1.58	0.40	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	18.58	5.31	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	13.30	1.90	1.14	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	32.47	1.91	1.49	0.85	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	20.57	1.19	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.58	2.01	0.75	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	13.07	3.57	1.66	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	23.02	2.99	0.46	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.41	1.05	1.68	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	17.33	2.45	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	26.17	1.93	1.07	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	11.34	1.78	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	14.67	1.75	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.10	1.01	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	16.58	3.26	1.09	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	12.06	0.29	1.18	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.17	0.96	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.81	2.00	2.00	0.80	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	1.37	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.51	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.45	0.88	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	1.10	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	12.15	1.49	0.74	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.26	2.09	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	20.17	2.05	1.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	1.75	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	15.98	2.13	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	19.36	3.37	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.21	2.49	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.16	1.17	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.08	0.90	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	20.87	2.09	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	22.17	1.85	0.92	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	21.63	2.28	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.62	2.21	0.97	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	17.88	2.33	0.26	1.04	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.87	1.29	1.29	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.07	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	20.02	3.47	0.53	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	35.92	4.19	2.10	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	18.50	2.12	0.71	0.42	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	17.84	3.50	0.64	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	27.20	3.32	1.33	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	13.27	1.14	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	35.23	5.68	2.27	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	25.56	5.41	1.23	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	15.64	1.96	1.96	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	30.28	3.53	1.47	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	31.43	2.88	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	47.40	6.18	6.59	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	25.31	3.57	0.60	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	48.97	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	3.56	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	35.16	2.96	2.63	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	21.04	3.16	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	46.06	2.37	2.37	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	21.42	0.93	3.73	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	34.55	1.88	0.75	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.31	1.07	0.80	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	51.80	2.38	2.49	0.57	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	2.95	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	30.05	0.73	0.73	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	35.78	1.56	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	60.93	4.81	3.21	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	25.25	1.01	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.08	2.11	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	54.48	2.72	2.72	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	24.80	5.09	0.64	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	39.68	1.62	2.43	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	1.51	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	114.20	11.42	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	202.27	39.15	9.79	9.79	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	32.96	2.80	1.08	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	29.27	2.09	0.00	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.10	1.25	0.83	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	63.89	2.66	1.90	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	35.11	4.79	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	169.06	5.51	7.35	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.14	0.84	0.84	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	15.81	1.16	0.46	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	16.75	1.62	0.54	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	35.53	2.94	1.26	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	289.50	55.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	25.31	1.99	0.00	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	40.33	2.71	0.27	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	16.09	0.91	1.36	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	17.80	0.49	0.49	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	43.01	1.64	0.91	0.00	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	28.64	1.06	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.61	1.80	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	94.51	8.53	1.64	2.63	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	19.19	1.14	0.16	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	39.51	3.88	1.41	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.17	1.41	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	24.36	0.92	0.46	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	24.74	1.61	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	84.50	6.55	1.72	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	278.13	17.70	7.59	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	35.42	2.23	1.56	0.45	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	20.32	1.69	1.27	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	42.01	1.66	0.95	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	20.17	2.15	0.86	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	451.39	54.17	9.03	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	21.33	0.67	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	20.74	2.25	1.35	0.00	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	14.68	1.19	0.79	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	35.29	0.00	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	41.62	3.03	1.51	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	15.97	2.28	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.64	0.44	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	41.61	2.71	1.36	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.93	0.00	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	33.91	1.33	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	24.80	0.99	0.50	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	20.67	1.53	1.15	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	51.42	3.63	0.60	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	31.83	3.32	0.66	0.44	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.30	2.03	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	250.37	5.11	15.33	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	33.53	1.83	1.83	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	18.88	1.26	1.26	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.88	0.91	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.90	1.58	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	120.17	5.67	2.27	2.27	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	293.36	10.12	15.17	0.00	0.00
Myoblast, donor1	11241-116D8	25.59	3.35	1.12	0.00	0.25
Myoblast, donor2	11322-117D8	23.78	1.73	0.58	0.00	0.00
Myoblast, donor3	11398-118D3	39.35	2.35	2.02	0.50	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	39.26	4.09	1.61	1.17	0.29
Natural Killer Cells, donor1	11230-116C6	108.55	18.14	14.76	2.46	1.54
Natural Killer Cells, donor2	11311-117C6	58.50	8.75	6.63	0.90	0.60
Natural Killer Cells, donor3	11387-118C1	63.68	9.57	7.73	2.02	1.10
Neural stem cells, donor1	11275-116H6	51.17	6.90	4.36	0.73	0.00
Neural stem cells, donor2	11352-117H2	78.95	9.63	7.70	0.00	0.00
Neurons, donor1	11494-119E9	54.62	6.83	0.00	3.41	0.00
Neurons, donor2	11574-120E8	54.38	7.05	0.88	0.44	0.00
Neurons, donor3	11655-122E8	58.37	9.04	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	150.34	11.14	7.42	3.71	0.00
Neutrophils, donor2	11314-117C9	95.66	2.90	8.70	2.90	0.00
Neutrophils, donor3	11390-118C4	254.72	12.22	15.88	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	36.93	2.73	1.19	0.59	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	6.51	0.65	0.65	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	15.64	0.60	0.20	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	26.43	2.20	1.10	0.14	0.41
Olfactory epithelial cells, donor2	11934-125I8	35.03	2.46	1.59	1.59	0.14
Olfactory epithelial cells, donor3	11935-125I9	33.14	2.04	1.14	0.00	0.11
Olfactory epithelial cells, donor4	11936-126A1	38.57	1.95	1.07	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	21.67	4.21	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	9.15	0.43	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	2.29	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.31	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	3.91	0.20	0.20	0.39	0.00
Osteoblast, donor2	11354-117H4	36.52	2.11	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	9.60	0.53	0.53	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	35.63	1.52	1.94	0.25	0.08
Pericytes, donor1	11491-119E6	7.01	0.11	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	7.70	0.00	0.23	0.23	0.00
Pericytes, donor3	11652-122E5	6.92	0.20	0.00	0.41	0.00
Perineurial Cells, donor1	11499-119F5	40.24	3.05	1.36	0.11	0.45
Perineurial Cells, donor2	11579-120F4	23.19	2.02	0.28	0.00	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	146.30	14.02	12.43	0.96	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	65.13	5.63	6.12	0.98	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	60.57	4.92	4.27	1.16	0.26
Placental Epithelial Cells, donor1	11278-116H9	8.13	0.24	1.20	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	13.31	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.53	0.20	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	10.13	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	27.95	1.88	0.75	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	94.24	5.61	2.87	0.91	0.65
Preadipocyte - breast, donor2	11328-117E5	12.61	0.68	0.45	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	29.41	4.37	1.39	0.64	0.11
Preadipocyte - omental, donor2	11329-117E6	27.93	2.18	2.62	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	17.33	2.72	0.43	0.29	0.43
Preadipocyte - perirenal, donor1	11469-119C2	8.86	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.45	0.92	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	17.00	1.77	0.18	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	11.58	0.68	0.85	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	35.86	1.68	1.21	0.09	0.09
Preadipocyte - visceral, donor2	11357-117H7	15.65	2.30	0.00	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	17.35	1.57	0.42	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	39.52	9.81	1.21	1.06	0.60
Prostate Epithelial Cells, donor2	11331-117E8	7.18	0.95	0.27	0.14	0.14
Prostate Epithelial Cells, donor3	11404-118D9	22.17	1.53	2.20	0.31	0.31
Prostate Stromal Cells, donor1	11254-116F3	22.67	3.19	2.28	0.80	0.11
Prostate Stromal Cells, donor2	11332-117E9	15.78	2.87	0.72	0.54	0.90
Prostate Stromal Cells, donor3	11405-118E1	18.67	1.25	0.73	0.42	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.39	0.36	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.35	2.29	1.04	0.14	0.00
Renal Epithelial Cells, donor1	11517-119H5	3.55	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.85	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	28.27	4.23	0.95	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	0.68	1.36	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.95	0.40	0.13	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	19.54	2.66	0.67	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.99	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	6.60	0.66	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.64	0.63	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	3.61	1.11	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.54	0.00	0.81	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.95	0.00	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	5.98	0.77	0.00	0.58	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	28.26	1.04	0.78	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.63	1.14	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	26.09	7.28	0.50	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	132.30	7.62	5.75	0.67	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	94.70	13.40	1.79	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	228.95	32.47	3.30	2.20	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	195.48	23.78	3.48	1.74	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	138.22	14.56	2.86	2.08	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	53.03	6.65	2.88	0.40	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	93.92	11.04	3.46	0.78	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	115.11	12.90	4.47	1.86	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	57.69	6.41	1.52	1.17	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	109.09	12.94	3.47	1.62	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	79.00	5.34	1.10	2.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	73.52	6.96	2.27	0.76	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	71.68	7.88	1.97	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	70.01	7.46	0.86	1.15	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	58.59	6.44	3.11	1.07	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	73.46	9.07	2.66	0.89	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	80.29	7.26	2.29	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	59.25	6.71	2.33	1.12	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	120.82	15.78	6.01	1.69	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	76.70	8.63	2.26	0.80	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	61.91	6.52	2.34	0.58	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	72.56	9.17	4.96	1.34	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	72.41	6.62	0.85	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	69.80	8.13	1.68	1.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	64.94	7.18	2.73	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	70.56	8.75	1.82	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	44.15	6.50	1.72	0.74	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	61.92	9.54	3.09	0.94	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	85.15	7.08	1.65	1.18	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	53.57	6.94	1.19	0.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	72.26	12.63	3.27	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	71.54	6.84	0.62	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	62.16	15.48	2.88	1.99	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	56.61	8.56	2.72	0.63	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	66.35	9.29	2.02	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	65.73	6.98	4.60	1.36	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	65.55	7.33	1.74	0.39	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	102.99	7.22	2.41	2.58	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	56.65	8.50	2.06	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	105.40	14.12	3.94	1.31	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	95.78	8.86	2.39	1.70	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	60.66	8.29	2.07	0.74	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	80.23	8.00	3.73	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	108.40	17.28	2.35	1.52	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	58.81	5.95	2.62	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	119.72	10.68	2.62	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	88.34	10.08	1.32	1.04	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	94.33	14.32	4.19	1.05	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	82.20	9.37	2.72	0.91	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	72.21	7.10	1.35	1.35	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	299.55	60.11	11.35	4.80	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	124.12	14.60	3.65	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	97.95	9.04	0.90	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	69.89	11.31	2.71	0.68	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	109.33	13.18	3.59	1.20	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	138.74	23.26	2.60	1.89	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	71.08	9.82	2.35	0.21	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	134.02	15.63	1.20	1.20	1.20
Schwann Cells, donor1	11498-119F4	4.70	0.75	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	20.41	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	10.30	0.88	0.66	0.22	0.00
Sebocyte, donor1	11220-116B5	11.50	1.10	1.10	0.55	0.00
Sebocyte, donor2	11301-117B5	9.19	0.46	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	3.92	0.62	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	28.16	1.66	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	19.77	11.30	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	28.24	2.20	1.14	0.09	0.09
Skeletal Muscle Cells, donor2	11358-117H8	3.61	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	5.85	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	29.53	3.61	0.00	0.16	0.47
Skeletal Muscle Cells, donor5	11455-119A6	20.07	2.82	1.19	0.00	0.30
Skeletal Muscle Cells, donor6	11459-119B1	27.39	1.54	1.54	0.46	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	54.06	6.80	1.64	0.76	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	22.26	3.00	0.29	0.29	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	24.31	2.48	0.40	0.30	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.01	2.61	0.67	0.25	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.79	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.09	0.28	0.14	0.00	0.28
Skin - palm, donor1	10286-104F7	123.56	0.00	13.43	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.49	0.58	0.00	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	226.56	29.44	1.64	5.73	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	7.40	0.52	0.39	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	21.96	2.78	1.39	0.00	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	16.32	1.69	1.41	0.28	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	185.44	15.22	8.03	1.27	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	12.37	1.20	1.20	0.15	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.34	1.54	0.31	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	68.48	4.89	1.56	0.89	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	7.05	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.62	0.66	0.00	0.22	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.36	0.39	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	11.59	1.55	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	38.03	5.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.99	0.27	0.67	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	14.85	0.89	1.11	0.00	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.25	2.18	0.90	0.38	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	31.91	3.26	0.98	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	34.85	1.77	2.07	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.51	1.28	0.28	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	3.74	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	26.49	2.74	1.22	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	9.34	0.76	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.20	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	31.12	1.77	0.88	0.29	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.02	2.80	0.00	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	19.31	2.31	0.52	0.42	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	3.87	0.46	0.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	1.08	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.78	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.49	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	47.35	6.99	1.18	0.71	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	15.80	1.51	1.71	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	14.34	2.05	0.23	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.62	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	36.03	4.77	0.26	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	43.14	3.06	1.73	0.53	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.41	3.63	0.63	1.00	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	22.07	1.27	0.51	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.64	1.51	0.15	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.75	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	2.58	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	15.35	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	2.52	0.50	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.15	0.31	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.13	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	29.57	1.25	1.25	0.25	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	18.69	1.87	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.76	0.43	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	7.65	0.51	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	4.89	0.38	0.00	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	25.99	2.66	0.56	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	20.95	2.26	0.59	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.85	0.49	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	33.36	3.09	0.66	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	31.01	1.46	2.05	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	30.51	1.75	0.78	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	25.92	3.97	1.85	0.00	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	51.70	6.70	2.60	0.74	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	32.70	5.03	1.08	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	16.18	2.84	0.85	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	38.99	1.18	0.79	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	35.30	2.79	1.27	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	34.74	2.80	0.80	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	28.42	3.34	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	35.75	1.38	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	21.38	1.18	0.67	0.50	0.17
Synoviocyte, donor2	11368-117I9	17.43	2.35	1.84	0.34	0.00
Synoviocyte, donor3	11440-118H9	18.99	2.01	1.34	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	8.22	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.34	1.16	0.69	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	13.40	0.93	0.43	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	6.57	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.29	0.57	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	136.31	8.24	6.52	0.86	1.85
Urethra, donor2	10319-105A4	163.66	12.59	14.39	1.80	0.00
Urothelial Cells, donor1	11520-119H8	3.72	0.80	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	4.81	0.40	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	2.98	0.46	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	20.51	2.23	0.45	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	202.87	9.79	9.79	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	235.89	17.16	10.01	2.86	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	58.18	5.48	3.42	0.00	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	165.28	11.02	14.12	1.72	2.41
Whole blood (ribopure), donor090325, donation2	12177-128I8	157.46	10.46	9.30	1.74	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	183.26	3.12	4.16	1.04	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	263.41	2.75	9.18	3.67	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	56.60	2.74	1.83	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	29.73	7.53	0.62	0.12	0.37
Wilms' tumor cell line:HFWT	10597-108E3	49.28	4.40	1.76	0.88	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	53.63	4.19	4.47	0.28	0.28
achilles tendon, donor2	10292-104G4	105.39	0.00	4.13	6.20	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	43.34	10.96	1.27	1.78	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	68.96	9.52	1.39	1.39	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	98.29	16.86	3.44	1.54	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	68.03	15.24	3.54	1.90	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	61.84	7.03	1.12	1.69	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	75.50	10.36	2.54	0.85	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	66.69	12.52	1.09	0.82	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	26.00	4.85	1.32	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	124.55	19.19	3.68	4.08	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	60.57	5.44	4.66	1.16	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	68.08	5.52	2.58	1.47	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	105.31	11.70	0.00	0.00	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	81.57	13.94	0.46	2.32	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	76.63	9.58	3.11	0.52	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	57.28	4.09	1.17	1.46	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	105.04	9.30	4.65	0.93	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	101.99	7.40	6.58	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	16.88	2.15	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	68.27	5.12	6.83	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	60.05	4.25	4.25	1.21	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	65.95	6.02	5.30	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	46.78	2.67	2.00	0.22	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	43.69	3.00	0.67	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	29.73	9.29	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	23.73	3.01	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	66.29	10.03	1.74	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	37.49	5.62	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	37.92	1.88	2.83	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	100.21	4.81	5.12	0.31	0.16
adipose, donor1	10184-103D4	153.64	32.84	4.10	4.69	1.17
adipose, donor2	10185-103D5	24.74	4.46	0.41	1.62	1.22
adipose, donor3	10186-103D6	35.67	10.35	1.09	2.18	0.27
adipose, donor4	10187-103D7	30.34	6.07	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	27.93	1.58	1.10	0.32	0.32
adrenal gland, adult, pool1	10081-102A9	47.29	3.64	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	23.48	2.27	1.87	0.27	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	41.09	2.50	3.57	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	38.95	2.09	3.48	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	46.66	0.68	0.68	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	60.39	1.77	1.47	0.00	0.00
amygdala - adult, donor10196	10167-103B5	125.69	10.67	2.37	2.37	0.00
amygdala, adult, donor10252	10151-102I7	131.60	9.94	5.27	1.82	0.61
amygdala, newborn, donor10223	10360-105E9	46.80	5.16	1.29	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	41.76	4.07	1.78	0.38	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	23.17	3.09	1.32	0.22	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	66.47	22.71	1.34	1.34	1.00
aorta, adult, pool1	10052-101G7	71.59	3.92	2.35	0.39	0.59
appendix, adult	10189-103D9	156.02	13.58	5.05	0.00	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	122.78	12.38	4.13	1.03	2.41
artery, adult	10190-103E1	74.73	10.87	9.51	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	64.76	6.23	2.03	0.58	0.00
b cell line:RPMI1788	10427-106D4	38.96	6.84	2.23	1.19	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	26.08	0.83	3.05	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	34.33	1.89	1.29	0.20	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	32.14	1.17	4.18	0.17	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	35.79	2.24	1.68	0.56	0.56
bladder, adult, pool1	10011-101C2	122.55	5.00	6.08	0.43	0.33
blood, adult, pool1	10053-101G8	42.08	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	36.82	0.00	2.57	0.00	0.00
bone marrow, adult	10192-103E3	75.58	7.42	4.05	0.00	0.00
brain, adult, donor1	10084-102B3	30.75	1.03	2.05	2.05	0.00
brain, adult, pool1	10012-101C3	89.31	7.57	5.79	0.11	0.33
brain, fetal, pool1	10085-102B4	32.06	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	70.37	7.93	5.62	0.99	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	106.85	4.99	6.74	0.75	0.37
breast, adult, donor1	10080-102A8	73.24	0.63	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	49.29	1.02	2.29	0.38	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	58.75	2.16	1.86	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	44.89	7.83	2.07	1.15	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	17.91	1.94	1.45	0.24	0.48
carcinoid cell line:NCI-H1770	10703-109H1	47.49	4.23	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	21.77	1.64	1.86	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	34.22	3.17	0.63	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	97.15	10.91	5.59	2.40	1.60
caudate nucleus - adult, donor10196	10177-103C6	207.24	9.21	6.91	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	133.36	11.04	5.02	0.84	1.00
caudate nucleus, adult, donor10258	10379-105H1	68.77	6.11	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	66.65	8.42	2.20	1.10	1.10
cerebellum - adult, donor10196	10173-103C2	387.47	11.65	14.57	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	345.89	12.60	15.37	1.71	2.99
cerebellum, adult, pool1	10083-102B2	84.51	5.86	5.52	1.03	0.00
cerebellum, newborn, donor10223	10357-105E6	217.54	22.42	4.15	0.00	0.00
cerebral meninges, adult	10188-103D8	78.92	4.54	4.79	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	57.74	6.58	5.12	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	33.07	1.73	3.02	0.29	0.29
cervical cancer cell line:ME-180	10553-107I4	39.61	3.98	1.82	0.17	0.17
cervix, adult, pool1	10013-101C4	187.41	9.45	6.40	1.15	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	25.22	4.46	1.81	0.42	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	70.22	10.44	3.98	1.86	0.37
choriocarcinoma cell line:SCH	10785-110H2	50.39	7.76	2.09	0.74	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	51.94	5.46	2.85	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	43.59	4.84	2.28	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	38.98	2.39	0.99	0.20	0.20
chorionic membrane cells, donor3	12240-129G8	76.93	7.14	1.10	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	26.25	8.08	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	54.56	3.65	2.11	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	79.41	8.66	2.75	1.06	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	34.67	2.05	1.80	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	31.44	3.14	0.97	0.24	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	34.82	1.63	1.83	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	39.46	2.94	2.36	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	126.92	19.81	2.61	2.35	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	22.86	4.11	0.46	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	27.41	1.74	1.39	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	49.06	9.88	1.65	1.10	0.00
colon carcinoma cell line:COLO-320	10420-106C6	195.36	14.82	7.22	0.38	0.38
colon, adult, donor1	10082-102B1	35.70	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	111.39	4.23	5.17	0.35	0.12
colon, fetal, donor1	10070-101I7	97.64	4.94	3.09	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	128.34	13.75	4.58	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	168.27	22.95	13.60	1.27	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	58.26	6.49	3.47	0.45	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	71.63	8.04	3.95	0.71	0.28
corpus callosum, adult, pool1	10042-101F6	112.88	7.19	5.53	0.44	0.77
cruciate ligament, donor2	10295-104G7	133.73	6.48	9.73	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	108.35	8.83	1.61	0.00	0.80
diencephalon, adult	10193-103E4	81.84	4.08	1.92	0.48	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	32.83	6.89	0.69	1.38	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	46.42	4.10	1.54	1.28	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	29.61	5.78	1.44	1.20	0.48
ductus deferens, adult	10196-103E7	150.00	5.98	8.97	1.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	103.70	11.52	2.88	0.00	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	160.37	11.77	5.89	2.94	0.74
dura mater, adult, donor1	10041-101F5	102.00	10.24	9.58	1.32	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	57.52	31.09	0.44	4.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	31.09	5.30	1.00	0.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	71.53	6.78	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	39.96	3.94	2.72	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	78.11	4.32	3.40	0.62	0.31
embryonic pancreas cell line:2C6	10603-108E9	135.29	2.63	2.63	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	26.48	3.02	1.01	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	71.41	7.07	5.07	0.91	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.85	1.77	1.77	0.96	0.00
epidermoid carcinoma cell line:A431	10426-106D3	31.90	3.11	1.33	0.22	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	24.64	1.65	1.87	0.11	0.22
epididymis, adult	10197-103E8	101.73	8.16	4.60	1.67	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	26.26	0.18	1.24	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.58	2.75	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	43.64	3.54	3.01	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	56.39	3.05	2.95	0.30	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	35.18	3.25	2.80	0.00	1.23
esophagus, adult, pool1	10015-101C6	81.54	3.29	3.50	0.11	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	131.37	26.30	7.76	1.88	0.63
eye - muscle inferior rectus, donor1	10272-104E2	222.14	24.15	12.07	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	138.88	10.52	4.21	2.10	2.10
eye - muscle medial, donor2	10299-104H2	135.43	4.46	4.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	157.07	8.03	5.73	2.29	1.15
eye - vitreous humor, donor1	10268-104D7	51.01	7.29	4.37	0.00	0.00
eye, fetal, donor1	10054-101G9	90.51	4.83	2.03	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	30.65	2.56	0.38	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	24.22	2.85	0.95	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	123.94	13.04	6.00	0.56	0.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	75.06	8.41	1.50	1.80	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	48.55	2.56	3.84	0.18	0.00
gall bladder, adult	10198-103E9	56.50	3.38	3.38	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	145.49	10.20	12.88	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	115.41	5.98	9.71	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	36.75	7.18	0.63	1.27	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	46.81	4.06	2.32	0.77	0.19
gastric cancer cell line:AZ521	10549-107H9	84.44	12.13	3.93	1.97	0.16
gastric cancer cell line:GSS	10560-108A2	32.03	7.32	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	41.58	17.82	0.69	1.37	0.46
giant cell carcinoma cell line:LU65	10487-107B1	21.34	1.49	2.29	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	61.02	6.72	3.92	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	56.62	3.74	3.49	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	30.29	5.38	1.27	0.21	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	34.13	3.93	1.83	0.84	0.00
glioblastoma cell line:T98G	10485-107A8	48.23	4.53	2.21	1.32	0.44
glioma cell line:GI-1	10413-106B8	46.57	4.69	2.64	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	154.53	7.29	2.92	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	208.94	9.28	8.79	0.49	3.17
globus pallidus, adult, donor10258	10367-105F7	127.34	10.95	12.32	2.74	1.37
globus pallidus, newborn, donor10223	10364-105F4	35.17	3.20	1.60	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	66.07	7.34	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	35.52	3.52	0.64	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	39.02	6.89	0.46	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	30.64	9.15	0.46	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	27.70	5.80	0.64	1.29	0.00
hIPS, biol_rep1	14380-156B6	35.93	11.50	1.44	1.44	0.00
hIPS, biol_rep2	14381-156B7	21.95	6.86	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	88.28	9.93	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	19.25	4.31	0.86	1.15	0.00
heart - mitral valve, adult	10205-103F7	114.80	8.37	5.08	0.90	0.60
heart - pulmonic valve, adult	10206-103F8	117.66	9.15	5.75	0.78	0.78
heart - tricuspid valve, adult	10207-103F9	172.36	10.82	2.50	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	30.81	2.65	2.45	1.02	0.61
heart, adult, diseased, donor1	10051-101G6	31.94	2.55	0.43	0.43	0.00
heart, adult, pool1	10016-101C7	54.73	2.07	1.84	0.00	0.23
heart, fetal, pool1	10046-101G1	191.91	12.73	5.96	0.62	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	39.49	2.78	1.23	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	28.54	4.76	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	28.07	9.94	0.77	1.10	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	34.59	8.01	1.21	1.46	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	45.17	10.81	1.21	1.92	0.81
hepatoma cell line:Li-7	10484-107A7	22.02	2.89	2.00	0.44	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	50.15	8.64	0.60	0.70	0.20
hippocampus - adult, donor10196	10169-103B7	145.73	11.36	0.95	0.95	0.95
hippocampus, adult, donor10252	10153-102I9	157.57	10.61	5.31	1.63	1.02
hippocampus, adult, donor10258	10374-105G5	109.55	7.47	1.00	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	34.90	5.64	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	87.89	20.14	3.66	2.44	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	31.02	9.43	0.20	1.37	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	32.50	10.92	1.27	2.03	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	28.76	7.89	1.13	1.13	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	47.51	16.01	1.29	4.91	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	40.24	12.91	0.76	1.90	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	55.47	16.35	0.00	4.38	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	45.02	13.36	0.86	3.88	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	44.63	12.10	0.42	1.67	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	49.49	10.18	1.89	1.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	39.05	13.98	1.77	1.45	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	53.86	10.10	2.02	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	29.89	6.73	0.63	0.94	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	52.08	12.28	0.98	1.97	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	66.33	24.44	0.87	3.49	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	42.00	14.13	0.19	2.86	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	41.86	12.65	0.87	0.00	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	67.47	15.49	1.00	5.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	35.61	12.43	2.26	0.94	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	49.56	10.91	0.91	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	32.26	9.40	0.63	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	36.58	9.63	1.63	1.47	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	31.64	11.61	0.87	1.45	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	31.09	9.57	1.20	1.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	28.82	11.45	0.92	0.74	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	29.67	9.98	0.57	2.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	44.10	13.47	1.22	2.86	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	47.53	19.72	1.41	2.46	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	31.67	9.50	0.95	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	28.75	9.68	0.30	1.21	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	34.65	8.79	1.55	1.55	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	44.50	12.62	0.00	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	35.14	8.72	0.77	1.80	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	43.20	8.18	1.02	1.53	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	51.49	8.33	0.76	2.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	34.95	10.08	1.01	0.67	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	30.67	8.45	0.48	2.17	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	42.78	10.25	0.89	2.23	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	36.10	11.22	0.98	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	36.98	13.45	1.83	1.22	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	471.72	165.92	19.52	42.29	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	54.61	20.85	0.66	4.63	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	46.52	12.59	1.09	2.74	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	35.10	10.49	1.81	3.26	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	32.38	13.88	0.36	2.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	42.96	13.13	0.00	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	61.48	13.81	2.03	1.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	32.33	5.39	0.81	1.89	0.54
immature langerhans cells, donor1	11904-125F5	72.16	15.98	3.87	4.84	0.00
immature langerhans cells, donor2	11905-125F6	42.78	1.58	0.79	1.58	0.00
insula, adult, pool1	10039-101F3	82.24	7.95	3.31	0.76	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	61.13	1.63	1.30	0.33	0.33
kidney, adult, pool1	10017-101C8	90.82	4.31	6.41	0.70	0.40
kidney, fetal, pool1	10045-101F9	56.59	3.18	1.41	0.50	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	56.67	9.09	2.56	0.85	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	15.07	1.80	0.55	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	22.94	1.47	0.92	0.00	0.18
left atrium, adult, donor1	10079-102A7	62.66	2.18	2.72	1.09	0.00
left ventricle, adult, donor1	10078-102A6	40.96	4.05	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	29.55	2.46	1.09	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	4.67	0.36	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	7.61	0.54	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	10.44	1.46	0.97	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	34.50	2.09	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	40.61	14.88	0.71	1.06	0.83
liposarcoma cell line:KMLS-1	10782-110G8	42.33	4.84	1.56	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	19.49	4.02	0.85	0.73	0.12
liver, adult, pool1	10018-101C9	44.40	3.73	3.89	0.65	0.00
liver, fetal, pool1	10086-102B5	28.22	1.88	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	126.72	11.23	4.37	1.17	0.87
locus coeruleus, adult, donor10252	10165-103B3	141.55	6.27	4.61	1.66	1.48
locus coeruleus, adult, donor10258	10375-105G6	73.64	8.46	2.82	1.13	0.00
locus coeruleus, newborn, donor10223	10362-105F2	100.95	15.14	6.31	2.10	0.42
lung adenocarcinoma cell line:A549	10499-107C4	29.06	1.11	1.11	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	31.71	1.38	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	22.01	0.79	1.05	0.00	0.00
lung, adult, pool1	10019-101D1	99.94	4.02	8.27	0.12	0.24
lung, fetal, donor1	10068-101I5	635.89	47.38	10.85	4.28	1.43
lung, right lower lobe, adult, donor1	10075-102A3	111.35	7.79	1.83	1.37	0.92
lymph node, adult, donor1	10077-102A5	63.43	3.79	5.21	1.42	0.47
lymphangiectasia cell line:DS-1	10727-110A7	26.96	3.51	1.53	0.88	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	40.15	7.24	0.75	1.21	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	102.79	24.64	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	40.85	3.55	4.44	0.89	0.00
mature adipocyte, donor2	12232-129F9	53.75	3.11	2.91	0.62	0.00
mature adipocyte, donor3	12233-129G1	48.60	1.66	2.84	0.24	0.24
mature adipocyte, donor4	12234-129G2	70.54	2.37	3.42	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	96.02	7.15	10.72	1.19	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	101.52	10.15	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	181.52	9.20	5.33	1.66	1.84
medial frontal gyrus, adult, donor10258	10368-105F8	74.34	6.99	1.91	1.27	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	134.34	18.34	4.26	2.99	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	152.04	18.90	5.23	2.70	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	184.00	10.19	4.88	0.64	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	107.87	9.63	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1478.42	114.83	100.48	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	39.84	3.59	1.79	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	167.44	9.09	5.19	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	147.68	7.12	7.89	1.08	1.70
medulla oblongata, adult, pool1	10038-101F2	73.14	5.63	4.65	0.57	0.57
medulla oblongata, newborn, donor10223	10361-105F1	64.58	3.82	1.74	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	133.73	20.15	3.76	1.77	0.44
medulloblastoma cell line:ONS-76	10759-110E3	18.22	1.35	0.37	0.24	0.00
melanoma cell line:COLO 679	10514-107E1	54.19	4.74	1.87	0.57	0.14
melanoma cell line:G-361	10465-106H6	38.28	3.53	1.09	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	18.27	2.89	1.45	0.72	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	130.41	15.86	3.52	6.17	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	78.03	9.33	2.85	1.81	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	24.09	1.99	1.07	0.15	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	26.90	3.64	0.18	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	25.67	1.24	0.83	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	21.35	1.26	0.42	0.42	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	19.64	3.27	1.35	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	25.68	1.39	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	24.20	3.26	1.20	0.51	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.13	1.61	0.46	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	25.07	3.18	0.80	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	22.69	2.03	0.95	0.41	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	30.87	1.99	0.57	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	36.56	3.62	0.99	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	32.10	2.35	0.83	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	24.09	2.09	0.70	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	27.56	1.63	0.82	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	23.36	1.80	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.83	2.07	1.03	0.21	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.50	2.28	0.23	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	39.86	4.20	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	25.11	1.20	0.60	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.73	2.45	0.88	0.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	42.34	2.95	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	27.47	4.58	2.00	0.57	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	33.26	6.32	1.26	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	24.20	1.37	0.91	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	27.88	2.81	1.79	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.46	2.36	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.18	1.85	0.62	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	26.36	4.24	0.47	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	20.65	4.06	0.68	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	19.65	1.96	0.39	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	17.15	2.32	0.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	31.15	2.60	1.15	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.09	2.01	0.00	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	23.07	2.40	0.72	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	41.80	5.13	2.93	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	18.46	1.68	0.34	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	17.60	2.05	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	21.91	2.15	0.00	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.86	1.95	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	2.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	20.79	3.20	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	4.09	0.00	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	17.49	1.17	1.17	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	0.00	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	18.88	2.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	22.53	1.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	30.46	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	16.47	3.17	0.63	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	24.14	0.69	1.72	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	2.15	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	16.30	1.22	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	18.27	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.97	1.77	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	18.08	2.18	1.25	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	18.92	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	0.00	2.57	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.03	2.75	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	19.30	1.48	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	1.12	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	21.63	1.27	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.10	2.01	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	3.80	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	44.30	1.82	1.82	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	4.52	0.00	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	33.77	4.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	21.83	2.18	0.79	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	21.09	0.97	0.32	0.32	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	14.26	3.06	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	99.04	6.19	3.09	0.77	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	26.22	3.78	2.13	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	25.25	6.95	0.93	1.16	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	25.17	4.42	0.72	1.03	0.31
mesothelioma cell line:Mero-25	10850-111F4	15.66	5.45	0.45	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	28.60	2.20	0.24	0.73	0.73
mesothelioma cell line:Mero-48a	10852-111F6	11.29	1.77	0.44	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	32.06	7.62	0.53	0.79	0.26
mesothelioma cell line:Mero-83	10854-111F8	27.58	2.72	0.85	0.85	0.00
mesothelioma cell line:Mero-84	10855-111F9	8.34	0.76	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	22.98	3.73	0.41	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	11.60	0.83	0.33	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	10.32	4.52	0.18	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	50.05	2.90	3.25	0.85	0.17
mesothelioma cell line:NCI-H28	10845-111E8	49.11	4.58	3.56	0.76	0.00
mesothelioma cell line:No36	10857-111G2	14.35	2.61	0.65	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	13.82	2.71	1.35	0.81	0.27
migratory langerhans cells, donor1	11901-125F2	76.19	18.04	4.41	4.03	0.38
migratory langerhans cells, donor2	11902-125F3	54.71	13.92	3.18	1.34	0.24
migratory langerhans cells, donor3	11903-125F4	77.36	21.54	2.33	3.23	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	37.87	6.86	0.65	0.65	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.08	2.54	0.42	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	43.77	4.38	2.07	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	23.98	2.47	1.52	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	137.30	5.73	6.10	0.92	0.92
myeloma cell line:PCM6	10474-106I6	51.79	5.53	0.99	1.19	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	26.89	1.01	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	14.32	0.39	0.78	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	19.95	1.23	1.45	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	26.18	1.84	2.65	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	20.42	3.31	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	171.17	34.28	3.91	2.07	1.38
neuroblastoma cell line:NB-1	10539-107G8	110.01	8.42	2.99	0.19	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	86.25	23.83	2.53	1.69	1.05
neuroblastoma cell line:NH-12	10555-107I6	109.20	12.49	2.05	2.24	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	109.12	13.52	3.56	2.14	1.42
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	58.60	10.14	2.38	0.79	2.06
neuroectodermal tumor cell line:TASK1	10774-110F9	33.21	3.62	0.00	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	31.79	2.54	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	27.15	3.19	0.53	0.53	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	190.43	25.54	5.07	2.37	1.69
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	47.23	4.00	2.40	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	40.40	3.85	0.64	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	19.18	3.15	0.00	0.79	0.00
nucleus accumbens, adult, pool1	10037-101F1	103.86	9.09	4.12	0.47	0.19
occipital cortex - adult, donor10196	10172-103C1	243.13	12.36	6.18	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	237.50	10.20	9.12	1.88	2.15
occipital cortex, newborn, donor10223	10355-105E4	50.95	6.91	2.55	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	81.61	8.66	3.41	1.05	0.79
occipital lobe, fetal, donor1	10073-102A1	136.02	10.73	0.43	2.15	0.43
occipital pole, adult, pool1	10036-101E9	28.62	2.13	1.02	0.08	0.16
olfactory region, adult	10195-103E6	106.22	8.41	2.67	1.72	0.96
optic nerve, donor1	10277-104E7	168.09	0.00	10.01	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	56.84	6.72	2.73	0.23	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	94.25	7.69	2.34	0.41	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	47.24	4.74	1.69	0.85	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	54.29	4.50	0.46	0.81	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	30.28	1.47	0.59	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	80.35	11.21	2.80	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	66.16	6.15	3.39	0.42	0.00
ovary, adult, pool1	10020-101D2	124.21	10.66	4.89	0.61	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.43	1.65	0.55	0.00	0.00
pancreas, adult, donor1	10049-101G4	34.80	2.82	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	61.78	9.22	3.35	1.96	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	39.52	4.26	2.38	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	54.48	2.32	3.64	0.33	0.33
paracentral gyrus, adult, pool1	10035-101E8	83.93	7.14	4.03	0.55	0.27
parietal cortex, adult, donor10258	10373-105G4	76.34	6.61	0.73	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	158.94	9.40	3.76	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	196.68	8.55	7.13	0.86	1.14
parietal lobe, adult, pool1	10034-101E7	68.47	7.67	2.82	0.18	0.35
parietal lobe, fetal, donor1	10072-101I9	168.75	29.10	9.70	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	54.96	9.72	0.75	1.12	0.00
parotid gland, adult	10199-103F1	37.62	1.23	1.23	0.62	0.00
penis, adult	10200-103F2	111.72	10.74	5.37	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	20.82	2.05	0.74	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	43.27	3.93	1.89	0.73	0.44
pineal gland - adult, donor10196	10179-103C8	272.20	10.97	7.74	0.65	1.29
pineal gland, adult, donor10252	10160-103A7	454.82	17.17	13.62	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	121.03	10.66	4.39	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	364.25	17.20	10.12	3.04	3.04
pituitary gland, adult, donor10252	10162-103A9	678.05	21.89	33.88	4.17	3.65
pituitary gland, adult, donor10258	10378-105G9	107.26	14.47	1.70	1.70	0.85
placenta, adult, pool1	10021-101D3	86.32	4.09	3.98	0.32	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	30.99	6.22	1.85	0.66	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	45.60	2.96	1.40	0.00	0.31
pons, adult, pool1	10033-101E6	116.10	9.30	6.28	0.52	0.60
postcentral gyrus, adult, pool1	10032-101E5	45.77	4.27	1.39	0.09	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	2.09	2.09	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	11.02	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	46.76	3.64	1.89	0.87	0.00
prostate cancer cell line:PC-3	10439-106E7	59.17	5.08	2.72	0.54	0.36
prostate, adult, pool1	10022-101D4	124.34	5.71	4.72	0.54	0.27
putamen, adult, donor10196	10176-103C5	159.11	13.46	5.19	0.94	3.07
putamen, adult, donor10252	10152-102I8	137.25	11.76	5.88	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	68.85	9.84	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	72.97	3.62	1.93	0.48	0.00
putamen, newborn, donor10223	10365-105F5	158.93	12.74	7.50	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	93.97	9.89	2.62	1.16	0.00
rectum, fetal, donor1	10067-101I4	140.49	6.95	4.17	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	44.52	4.88	3.18	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.61	0.00	4.56	0.83	0.00
retina, adult, pool1	10030-101E3	88.47	3.88	6.56	0.60	0.30
retinoblastoma cell line:Y79	10475-106I7	93.01	10.39	2.34	2.08	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	36.27	12.54	0.74	0.86	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	144.82	16.87	4.22	1.12	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	35.62	2.27	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	39.65	2.43	0.81	0.81	0.32
salivary acinar cells, donor2	11772-123I8	51.91	2.62	2.34	0.28	0.28
salivary acinar cells, donor3	11773-123I9	81.43	4.63	2.65	0.00	1.32
salivary gland, adult, pool1	10093-102C3	89.22	5.72	4.00	0.00	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	51.26	3.79	3.63	0.67	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	60.77	3.06	3.76	0.35	0.24
seminal vesicle, adult	10201-103F3	122.22	8.99	7.94	3.70	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	74.82	11.66	4.62	1.21	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	27.18	1.01	1.01	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	32.11	1.00	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	29.42	4.97	0.67	0.81	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	64.66	6.41	4.42	0.88	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	28.39	1.94	1.68	0.13	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	111.37	12.06	5.67	0.71	1.42
skeletal muscle, adult, pool1	10023-101D5	81.80	5.28	5.28	0.48	0.12
skeletal muscle, fetal, donor1	10066-101I3	49.25	0.00	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	81.42	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	151.49	9.47	8.21	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	49.03	2.67	1.33	1.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	67.45	10.09	0.63	1.89	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	41.44	1.54	2.89	0.19	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	110.27	12.03	7.25	0.82	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	88.95	11.42	5.15	1.13	2.09
small cell lung carcinoma cell line:WA-hT	10562-108A4	52.08	10.02	1.09	0.65	0.65
small intestine, adult, pool1	10024-101D6	119.08	5.61	7.76	0.48	0.48
small intestine, fetal, donor1	10064-101I1	64.13	4.91	3.93	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	159.51	13.34	9.23	3.08	0.51
smooth muscle, adult, pool1	10048-101G3	112.43	3.10	5.94	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	46.37	4.29	1.34	0.54	0.54
spinal cord - adult, donor10196	10181-103D1	194.31	20.19	5.05	1.61	1.38
spinal cord, adult, donor10252	10159-103A6	250.36	14.98	9.07	0.79	0.79
spinal cord, adult, donor10258	10369-105F9	201.31	17.99	3.46	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	99.40	9.15	2.44	1.83	0.61
spinal cord, newborn, donor10223	10359-105E8	188.28	19.75	5.51	1.38	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	27.03	2.24	0.30	0.30	0.15
spleen, adult, pool1	10025-101D7	104.19	4.85	4.63	0.44	0.22
spleen, fetal, pool1	10044-101F8	55.46	3.10	2.07	0.48	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	35.09	8.18	2.28	1.14	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	85.63	9.11	2.28	0.95	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	46.83	4.19	1.75	1.05	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	26.97	5.08	1.56	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	33.32	2.03	1.35	0.23	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	29.65	2.97	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	27.50	5.92	0.85	0.85	0.42
stomach, fetal, donor1	10062-101H8	72.62	5.34	3.20	1.07	2.14
submaxillary gland, adult	10202-103F4	103.11	2.28	2.85	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	1465.40	54.27	108.55	108.55	108.55
substantia nigra, adult, donor10252	10158-103A5	171.77	5.19	7.48	1.04	3.12
substantia nigra, adult, donor10258	10371-105G2	107.07	6.21	1.03	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	80.55	9.19	2.12	2.12	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	122.89	10.55	4.36	2.52	0.69
temporal lobe, adult, pool1	10031-101E4	27.89	1.78	0.68	0.34	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	164.53	17.09	2.14	1.42	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	116.92	10.11	1.76	0.88	0.00
tenocyte, donor1	11763-123H8	23.74	2.79	0.35	0.70	0.35
tenocyte, donor2	11765-123I1	29.76	3.05	0.38	1.14	0.76
tenocyte, donor3	11768-123I4	22.24	2.97	0.00	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	33.48	16.83	0.34	2.89	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	35.45	6.47	0.46	0.62	0.46
teratocarcinoma cell line:PA-1	10807-111A6	46.96	9.30	1.08	1.55	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	36.18	15.61	2.29	2.67	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	28.74	14.37	1.13	1.51	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	30.10	15.16	1.85	1.96	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	32.90	15.63	0.98	4.56	0.33
testis, adult, pool1	10026-101D8	94.27	5.26	9.45	0.54	0.11
testis, adult, pool2	10096-102C6	59.09	6.32	5.41	0.45	1.35
thalamus - adult, donor10196	10168-103B6	198.72	6.62	3.31	2.21	1.10
thalamus, adult, donor10252	10154-103A1	176.29	10.78	5.78	0.63	2.19
thalamus, adult, donor10258, tech_rep1	10370-105G1	104.69	6.16	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	61.26	5.43	2.14	1.48	0.33
thalamus, newborn, donor10223	10366-105F6	69.04	7.48	2.30	0.58	0.00
throat, adult	10209-103G2	117.59	6.74	5.24	2.00	0.25
throat, fetal, donor1	10061-101H7	134.07	11.27	3.05	3.05	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	59.42	22.26	0.99	3.38	1.39
thymus, adult, pool1	10027-101D9	143.06	16.80	4.18	1.19	0.00
thymus, fetal, pool1	10043-101F7	221.52	26.81	6.03	3.32	0.83
thyroid carcinoma cell line:KHM-5M	10776-110G2	39.49	4.12	1.99	0.40	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	30.45	1.82	0.98	0.14	0.28
thyroid, adult, pool1	10028-101E1	135.58	6.91	6.53	1.40	0.28
thyroid, fetal, donor1	10060-101H6	117.33	11.07	4.75	1.05	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	110.87	15.40	9.24	0.00	0.00
tongue, adult	10203-103F5	79.31	5.58	5.81	1.40	0.23
tongue, fetal, donor1	10059-101H5	78.03	6.31	3.15	0.39	0.39
tonsil, adult, pool1	10047-101G2	81.34	4.51	4.61	0.60	0.20
trachea, adult, pool1	10029-101E2	84.58	3.84	3.84	0.49	0.74
trachea, fetal, donor1	10058-101H4	115.79	12.31	3.08	0.77	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.49	3.54	2.13	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	56.53	7.90	1.72	0.61	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	59.07	9.56	1.88	0.78	0.78
tridermal teratoma cell line:HGRT	10694-109G1	62.78	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	34.62	2.88	1.35	0.17	0.25
umbilical cord, fetal, donor1	10057-101H3	64.68	4.17	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	221.65	12.11	5.29	0.51	0.34
uterus, fetal, donor1	10055-101H1	120.30	13.31	2.56	1.02	2.05
vagina, adult	10204-103F6	105.98	3.88	7.11	0.00	0.00
vein, adult	10191-103E2	62.25	4.60	1.97	1.10	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	17.36	4.81	0.00	0.80	0.53